Back to Search
Start Over
Immunotherapy of HPV-associated head and neck cancer: critical parameters
- Source :
- OncoImmunology, OncoImmunology, Taylor & Francis, 2013
- Publication Year :
- 2013
- Publisher :
- HAL CCSD, 2013.
-
Abstract
- Various arguments support the development of a vaccine targeting human papillomavirus (HPV) for the treatment of HPV-associated head and neck cancer. However, the mucosal localization of this tumor, the HPV-driven downregulation of MHC Class I molecules and various other immunosuppressive mechanisms must be carefully considered to improve the clinical efficacy of such an immunotherapeutic strategy.
- Subjects :
- HPV
medicine.medical_treatment
Immunology
head and neck
Downregulation and upregulation
MHC class I
medicine
Immunology and Allergy
Clinical efficacy
Human papillomavirus
[SHS.LANGUE]Humanities and Social Sciences/Linguistics
Head and neck
Mucosal immunity
ComputingMilieux_MISCELLANEOUS
biology
business.industry
Head and neck cancer
virus diseases
Immunotherapy
medicine.disease
female genital diseases and pregnancy complications
PD1
Oncology
[ SHS.LANGUE ] Humanities and Social Sciences/Linguistics
biology.protein
Cancer research
mucosal immunity
immunotherapy
business
Subjects
Details
- Language :
- English
- ISSN :
- 21624011 and 2162402X
- Database :
- OpenAIRE
- Journal :
- OncoImmunology, OncoImmunology, Taylor & Francis, 2013
- Accession number :
- edsair.doi.dedup.....6e1d5f847d34da7100abc27cbc36ef6e